1 March 2017 – WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On 1 March 2017, India delivered the following statement during WTO TRIPS Council discussions on the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.
Agenda item 12: the United Nations Secretary-General’s High Level Panel Report on Access to MedicinesThank you Chairman.
At the outset, I would like to thank delegations of Brazil, China and South Africa who are also co-sponsors of this agenda item.
1 March 2017 – WTO TRIPS Council – Brazil’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On 1 March 2017, Brazil delivered the following statement during WTO TRIPS Council discussions on the Report of the United Nations High-Level Panel on Access to Medicines.
High Level PanelAs we all know, on 19 November 2015, United Nations Secretary General Ban Ki-moon announced the creation of the High-Level Panel on Innovation and Access to Health Technologies. Responding to this invitation, two chairs were designated to the panel, namely, Ms. Ruth Dreifuss, from Switzerland, and Festus Mogae, from Botswana.
WTO TRIPS Council: Brazilian submission on Ecommerce and Copyright
In December 2016, Brazil submitted a proposal to the World Trade Organization entitled, ELECTRONIC COMMERCE AND COPYRIGHT (JOB/GC/113, JOB/IP/19), intended for circulation at the WTO’s General Council and the TRIPS Council. This paper will be discussed at the next session of the TRIPS Council under agenda item 13, “Work Programme on Electronic Commerce” (1-2 March 2017).
WTO Trade Policy Review: Members question the United States on compulsory licensing, Bayh-Dole, UNHLP & Section 337
In December 2016, during the twilight of President Barack Obama’s 44th presidency, the World Trade Organization (WTO) conducted a Trade Policy Review (TPR) of the United States of America. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The TPRM takes place in the “Trade Policy Review Body which is actually the WTO General Council — comprising the WTO’s full membership — operating under special rules and procedures” (Source: WTO, Trade Policy Reviews: Brief Introduction).
9 November 2016 – WTO TRIPS Council – Holy See’s statement on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, H.E. Archbishop Ivan Jurkovic, (Holy See) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines
Statement by H.E. Archbishop Ivan Jurkovic , Permanent Observer of the Holy See to the United Nations and Other International Organizations in Geneva at the World Trade Organization (WTO) Trade Related Intellectual Property Rights (TRIPs) Council, Geneva, 9 November 2016
Mr. President,
9 November 2016 – WTO TRIPS Council – EU’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, the European Union delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.
UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES
The European Commission takes note of the contribution provided by the Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines.
9 November 2016 – WTO TRIPS Council – EU’s intervention on Intellectual Property and Innovation – Regional Innovation Models
Australia, the European Union, Japan, Switzerland, Chinese Taipei and the United States requested the Secretariat of the World Trade Organization (WTO) to place an item on the agenda of the November 2016 TRIPS Council agenda entitled – “Intellectual Property and Innovation: Regional Innovation Models. On 9 November 2016, the European Union delivered the following intervention on regional innovations models. Intellectual Property and Innovation have been on the agenda of the TRIPS Council since 2012.
IP AND INNOVATION: REGIONAL INNOVATION MODELS
9 November 2016 – WTO TRIPS Council – UNCTAD’s statement on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, the United Nations Conference on Trade and Development (UNCTAD) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines. UNCTAD informed WTO members that the agency had recently recommended to Secretary-General Ban Ki-moon to consider endorsement of the Report of the High Level Panel.
9 November 2016 – WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, India delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.
Agenda item 13: the United Nations Secretary-General’s High Level Panel Report on Access to Medicines
Statement by India.
Thank you Chairman.
At the outset, I would like to thank delegations of Brazil, China and South Africa who are also co-sponsors of this agenda item.
9 November 2016 – WTO TRIPS Council – WHO’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On Wednesday, 9 November 2016, the World Health Organization (WHO) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.
COUNCIL FOR TRIPS
8-9 NOVEMBER 2016
WHO STATEMENT
13. THE UNITED NATIONS SECRETARY-GENERAL’S HIGH LEVEL PANEL REPORT ON ACCESS TO MEDICINES
Thank you very much for giving WHO the opportunity to share our feedback on the Report of the High-Level Panel on Access to Medicines.